← Back to Search

EyeControl Eye-tracking Device for Acute Respiratory Failure

N/A

Waitlist Available

Led By Ofer Sadan, MD, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to extubation or icu discharge (up to 5 days, on average)

Awards & highlights

Study Summary

This trial will test how well a wearable communication device, the EyeControl, works for critically ill patients who are admitted to the ICU and mechanically ventilated.

Eligible Conditions

Acute Respiratory Failure Requiring Mechanical Ventilation

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to extubation or icu discharge (up to 5 days, on average)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to extubation or icu discharge (up to 5 days, on average)

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to extubation or icu discharge (up to 5 days, on average) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants Successfully Operating the EyeControl Device Per Attempt Day

Number of Participants Who Succeeded in Operating the EyeControl Device

Time To Successful Operation of the EyeControl Device

Secondary outcome measures

Days of Use

Other outcome measures

Confusion Assessment Method in Intensive Care Unit (CAM-ICU) Validation

Wakefulness Monitoring

Trial Design

1Treatment groups

Experimental Treatment

Group I: EyeControl Eye-tracking DeviceExperimental Treatment1 Intervention

Ventilated ICU patients using the EyeControl wearable, eye-tracking device.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EyeControl Eye-tracking Device

2021

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Eyefree Assisting Communication LtdIndustry Sponsor

2 Previous Clinical Trials

175 Total Patients Enrolled

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,543 Total Patients Enrolled

Ofer Sadan, MD, PhDPrincipal Investigator - Emory University

Emory University Hospital, Emory University Hospital Midtown, Select Specialty Hospital-Atlanta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are trialing this treatment currently?

"Affirmative. Information accessible through clinicaltrials.gov reveals that this scientific research is actively searching for participants; it was first posted on May 19th 2021 and recently revised on April 13th 2022. The study necessitates the recruitment of 60 patients from 1 medical facility."

Answered by AI

Is enrollment for the experiment currently open?

"As per the details on clinicaltrials.gov, this medical study is currently open for recruitment. The investigation was first made available to patients on May 19th 2021 and has been recently refreshed as of April 13th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication

Ofer Sadan 2021. "Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04582149.